Brief: Soligenix Announces Positive Clinical Results From Compatibility Study Of Hybryte™ In The Treatment Of Cutaneous T-Cell Lymphoma
04/05/2023 12:47
May 4 (Reuters) - Soligenix Inc SNGX.O :
* SOLIGENIX ANNOUNCES POSITIVE CLINICAL RESULTS FROM
COMPATIBILITY
STUDY OF HYBRYTE™ IN THE TREATMENT OF CUTANEOUS T-CELL LYMPHOMA
* SOLIGENIX INC - RESULTS CONFIRM AND EXTEND RESPONSE
RESULTS FROM
PHASE 3 FLASH STUDY
Source text for Eikon: ID:nPn6MG5ZMa
Further company coverage: SNGX.O